Discover 2,017 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,017
Experimental and Clinical Studies of Retinal Stimulation
for
Retinitis Pigmentosa
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 25 - 70+
Code: NCT03635645
Recruiting
STRIDE Biorepository
for
Anemia, Sickle Cell
Location: Bronx NY, New York NY, Brooklyn NY, Hackensack NJ,
Sponsor: Emory University
Sex: All
Age: 15 - 40
Code: NCT02843347
Recruiting
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Providence RI, New Haven CT, The Bronx NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 6 - 39
Code: NCT05702645
Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Halifax, Shirley NY, New York NY, Belleville NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
for
Liver Dysfunction
Location: Detroit MI
Sponsor: University of Alberta
Sex: All
Age: 18+
Code: NCT03193151
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Washington D.C. DC, Durham NC, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 39
Code: NCT05843253
Phase 2, Recruiting
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC),
Location: Boston MA, New York NY, Sarasota FL, Columbus OH,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06784193
Phase 1, Recruiting
Home-based Transitional Telecare for Older Veterans
Location: Hartford CT, Brooklyn NY, West Reading PA, Cleveland OH,
Sponsor: Hospital Quality Foundation
Sex: All
Age: 18+
Code: NCT02745054
Recruiting
Effectiveness of Aurix Therapy in Venous Leg Ulcers
for
Venous Leg Ulcers
Location: Boston MA, Bristol CT, Middletown NY, Harris NY,
Sponsor: Nuo Therapeutics
Sex: All
Age: 18+
Code: NCT02352454
Recruiting
Use of Stratafix Symmetricâ„¢ to Prevent Incisional Hernia in Gastrointestinal and Abdominal Surgery
for
C.Surgical Procedure; Disruption of Wound, Suture
Location: Kalamazoo MI
Sponsor: West Michigan Cancer Center
Sex: All
Age: 18+
Code: NCT06063577
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Saint John, South Portland ME, West Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase 3, Recruiting
CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction
for
Ischemic Heart Failure
Location: Clearwater FL, Detroit MI, Atlanta GA, Madison WI
Sponsor: BioCardia, Inc.
Sex: All
Age: 21 - 70+
Code: NCT06258447
Recruiting
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Location: Boston MA, Rochester NY, Chapel Hill NC, Detroit MI,
Sponsor: Opna Bio LLC
Sex: All
Age: 18+
Code: NCT06433947
Phase 1, Recruiting
ATLAS (AltaValve) Pivotal Trial
for
Mitral Regurgitation, Mitral Insufficiency,
Location: Boston MA, Quebec, The Bronx NY, New York NY,
Sponsor: 4C Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT06465745
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer